Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats

Journal of Physiology

Volumn 586, Issue 2, 2008, Pages 659-671

  Pauli, José R ^a   Ropelle, Eduardo R ^a   Cintra, Dennys E ^a   Carvalho Filho, Marco A ^a   Moraes, Juliana C ^a   De Souza, Cláudio T ^a   Velloso, Lício A ^a   Carvalheira, José B C ^a   Saad, Mario J A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE B; S NITROSOGLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; HORMONE ACTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; MALE; NITROSATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SWIMMING; TISSUE DISTRIBUTION; DIET INDUCED OBESITY; GASTROCNEMIUS MUSCLE; PROTEIN PHOSPHORYLATION; WISTAR RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DIET; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INSULIN RESISTANCE; LYSINE; MALE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; PHYSICAL CONDITIONING, ANIMAL; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION;

EID: 38149095759     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.142414     Document Type: Article

References (47)

1. Arias EB, Kim J, Funai K & Cartee GD (2007). Prior exercise increases phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle. Am J Physiol Endocrinol Metab 292, E1191-E1200.
2. Balon TW & Nadler JL (1997). Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82, 359-363.
3. Bedard S, Marcotte B & Marette A (1997). Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J 325, 487-493.
4. Betts JJ, Sherman WM, Reed MJ & Gao JP (1993). Duration of improved muscle glucose uptake after acute exercise in obese Zucker rats. Obes Res 1, 295-302.
5. Bisquolo VA, Cardoso CG Jr, Ortega KC, Gusmao JL, Tinucci T, Negrao CE, Wajchenberg BL, Mion D Jr & Forjaz CL (2005). Previous exercise attenuates muscle sympathetic activity and increases blood flow during acute euglycemic hyperinsulinemia. J Appl Physiol 98, 866-871.
6. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A & Muggeo M (1989). Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68, 374-378.
7. Broillet MC & Firestein S (1996). Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds. Neuron 16, 377-385.
8. Bruce CR, Lee JS & Hawley JA (2001). Postexercise muscle glycogen resynthesis in obese insulin-resistant Zucker rats. J Appl Physiol 91, 1512-1519.
9. Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA & Saad MJ (2006). Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab 291, E476-E482.
10. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R & Saad MJ (2005). S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/ Akt: A novel mechanism of insulin resistance. Diabetes 54, 959-967.
11. Chibalin AVYuM, Ryder JW, Song XM, Galuska D, Krook A, Wallberg-Henriksson H & Zierath JR (2000). Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: Differential effects on insulin-receptor substrates 1 and 2. Proc Natl Acad Sci U S A 97, 38-43.
12. Devlin JT, Hirshman M, Horton ED & Horton ES (1987). Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 36, 434-439.
13. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML & Kennedy BP (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548.
14. Fiedler M, Zierath JR, Selen G, Wallberg-Henriksson H, Liang Y & Sakariassen KS (2001). 5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia 44, 2180-2186.
15. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs SYuJ, Kempf W, Schubert A, Schuler G & Hambrecht R (2003). Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42, 861-868.
16. Gross SS & Wolin MS (1995). Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol 57, 737-769.
17. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M & Hotamisligil GS (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333-336.
18. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF & Spiegelman BM (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668.
19. Jaffrey SR & Snyder SH (2001). The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001 (86), PL1.
20. Kapur S, Bedard S, Marcotte B, Cote CH & Marette A (1997). Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes 46, 1691-1700.
21. Kapur S, Marcotte B & Marette A (1999). Mechanism of adipose tissue iNOS induction in endotoxemia. Am J Physiol Endocrinol Metab 276, E635-E641.
22. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
23. Lancaster GI, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT & Gleeson M (2005). The physiological regulation of toll-like receptor expression and function in humans. J Physiol 563, 945-955.
24. Lander HM, Ogiste JS, Pearce SF, Levi R & Novogrodsky A (1995). Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem 270, 7017-7020.
25. Lane P & Gross SS (1999). Cell signaling by nitric oxide. Semin Nephrol 19, 215-229.
26. Liu L, Zhang Y, Chen N, Shi X, Tsang B & Yu YH (2007). Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117, 1679-1689.
27. Martinez-Ruiz A & Lamas S (2004). Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423, 192-199.
28. McGrowder D, Ragoobirsingh D & Brown P (2006). Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds. J Biosci 31, 347-354.
29. Molina y Vedia L, McDonald B, Reep B, Brune B, Di Silvio M, Billiar TR & Lapetina EG (1992). Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem 267, 24929-24932.
30. Perreault M & Marette A (2001). Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7, 1138-1143.
31. Pilon G, Dallaire P & Marette A (2004). Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: A new mechanism of action of insulin-sensitizing drugs. J Biol Chem 279, 20767-20774.
32. Richter EA, Garetto LP, Goodman MN & Ruderman NB (1982). Muscle glucose metabolism following exercise in the rat: Increased sensitivity to insulin. J Clin Invest 69, 785-793.
33. Ropelle ER, Pauli JR, Prada PO, de Souza CT, Picardi PK, Faria MC, Cintra DE, Fernandes MF, Flores MB, Velloso LA, Saad MJ & Carvalheira JB (2006). Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: The role of PTP1B and IRS-1 serine phosphorylation. J Physiol 577, 997-1007.
34. Saad MJ, Maeda L, Brenelli SL, Carvalho CR, Paiva RS & Velloso LA (1997). Defects in insulin signal transduction in liver and muscle of pregnant rats. Diabetologia 40, 179-186.
35. Schenk S & Horowitz JF (2007). Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117, 1690-1698.
36. Scott MD, Kuypers FA, Butikofer P, Bookchin RM, Ortiz OE & Lubin BH (1990). Effect of osmotic lysis and resealing on red cell structure and function. J Lab Clin Med 115, 470-480.
37. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H & Flier JS (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015-3025.
38. Shishido SM, Seabra AB, Loh W & Ganzarolli de Oliveira M (2003). Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: Potential uses for local and controlled nitric oxide release. Biomaterials 24, 3543-3553.
39. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ & Loscalzo J (1992). S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 89, 444-448.
40. Stamler JS, Toone EJ, Lipton SA & Sucher NJ (1997). (S) NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691-696.
41. Sugita H, Fujimoto M, Yasukawa T, Shimizu N, Sugita M, Yasuhara S, Martyn JA & Kaneki M (2005). Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280, 14203-14211.
42. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA & Saad MJ (2007). Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998.
43. Wallberg-Henriksson H (1987). Glucose transport into skeletal muscle. Influence of contractile activity, insulin, catecholamines and diabetes mellitus. Acta Physiol Scand Suppl 564, 1-80.
44. Wallberg-Henriksson H, Constable SH, Young DA & Holloszy JO (1988). Glucose transport into rat skeletal muscle: Interaction between exercise and insulin. J Appl Physiol 65, 909-913.
45. Winder WW (2000). AMP-activated protein kinase: Possible target for treatment of type 2 diabetes. Diabetes Technol Ther 2, 441-448.
46. Wojtaszewski JF, Birk JB, Frosig C, Holten M, Pilegaard H & Dela F (2005). 5′AMP activated protein kinase expression in human skeletal muscle: Effects of strength training and type 2 diabetes. J Physiol 564, 563-573.
47. Zierath JR (1995). In vitro studies of human skeletal muscle: Hormonal and metabolic regulation of glucose transport. Acta Physiol Scand Suppl 626, 1-96.